NEWAMSTERDAM PHARMA CO NV (NAMS) Stock Earnings Estimates
NASDAQ:NAMS • NL00150012L7
34.86 USD
+0.62 (+1.81%)
At close: Feb 12, 2026
34.86 USD
0 (0%)
After Hours: 2/12/2026, 8:03:28 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 97.5M | 13.254M -86.41% | 32.622M 146.13% | 28.148M -13.71% | 31.093M 10.46% | 209.45M 573.62% | 400.85M 91.38% | 764.09M 90.62% | 1.134B 48.41% | 1.34B 18.17% | 1.602B 19.55% | 1.975B 23.28% | |||
| EBITDA YoY % growth | -126.7K | -1.352M -967.32% | -3.867M -185.96% | -218.688M -5,555.24% | -192.78M 11.85% | -214.302M -11.16% | -179.305M 16.33% | 64.381M 135.91% | 708.13M 999.91% | 1.381B 95.02% | 1.615B 16.94% | N/A | N/A | N/A | |
| EBIT YoY % growth | -127.7K | -1.366M -969.93% | -3.939M -188.30% | -192.371M -4,783.75% | -190.345M 1.05% | -212.044M -11.40% | -230.707M -8.80% | -186.469M 19.17% | 10.892M 105.84% | 324.52M 2,879.43% | 671.02M 106.77% | 847.62M 26.32% | 1.022B 20.57% | 1.346B 31.70% | |
| Operating Margin | N/A | N/A | -4.04% | -1,451.42% | -583.49% | -753.32% | -741.99% | -89.03% | 2.72% | 42.47% | 59.17% | 63.26% | 63.80% | 68.15% | |
| EPS YoY % growth | N/A | N/A | N/A | -2.21 -1,306.89% | -2.12 -16.91% | -1.49 42.32% | -1.75 -17.52% | -1.25 28.37% | -0.24 81.03% | 1.93 912.36% | 3.76 94.98% | 4.16 10.63% | 5.50 31.99% | 6.93 26.07% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.39 58.14% | -0.47 -38.86% | -0.49 -223.48% | -0.51 15.92% | -0.40 -2.62% | -0.51 -8.02% | -0.58 -19.82% | -0.53 -3.41% | -0.47 -17.45% |
| Revenue Q2Q % growth | 5.465M -57.21% | -100.00% | -100.00% | 81.6K -76.55% | 390.405K -92.86% | 734.4K | 1.112M | 7.477M 9,062.99% | 13.474M 3,351.29% |
| EBITDA Q2Q % growth | -53.156M | -80.233M | -83.77M | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -52.54M 3.23% | -67.115M -15.50% | -70.066M -7.41% | -70.713M -32.61% | -73.776M -40.42% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.61 -238.89% | -0.40 | -0.21 | -50.97% |
| Q2 2025 Q2Q % growth | -0.15 63.41% | -0.50 | 0.35 | 70.09% |
| Q1 2025 Q2Q % growth | -0.34 67.92% | -0.50 | 0.16 | 31.66% |
| Q4 2024 Q2Q % growth | -0.93 -60.07% | -0.50 | -0.43 | -87.61% |
| Q3 2024 Q2Q % growth | -0.18 67.54% | -0.51 | 0.33 | 64.67% |
| Q2 2024 Q2Q % growth | -0.41 11.09% | -0.59 | 0.18 | 30.32% |
| Q1 2024 Q2Q % growth | -1.06 -142.72% | -0.54 | -0.52 | -97.14% |
| Q4 2023 Q2Q % growth | -0.58 -18.67% | -0.61 | 0.03 | 4.67% |
| Q3 2023 Q2Q % growth | -0.55 9.31% | -0.50 | -0.06 | -11.52% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 348K -98.80% | 5.392M | -5.044M | -93.55% |
| Q2 2025 Q2Q % growth | 19.145M 740.06% | 1.63M | 17.515M | 1,074.54% |
| Q1 2025 Q2Q % growth | 2.978M 112.56% | 1.607M | 1.371M | 85.31% |
| Q4 2024 Q2Q % growth | 12.772M 1,521.66% | 1.791M | 10.981M | 613.12% |
| Q3 2024 Q2Q % growth | 29.111M 877.73% | 1.91M | 27.201M | 1,424.14% |
| Q2 2024 Q2Q % growth | 2.279M -76.17% | 1.406M | 873K | 62.09% |
| Q1 2024 Q2Q % growth | 1.401M -49.86% | 1.778M | -377K | -21.20% |
| Q4 2023 Q2Q % growth | 787.59K -99.19% | 1.998M | -1.21M | -60.58% |
| Q3 2023 Q2Q % growth | 2.977M | 2.291M | 686.42K | 29.96% |
| Q2 2023 Q2Q % growth | 9.562M | 2.794M | 6.768M | 242.23% |
| Q4 2022 Q2Q % growth | 97.5M | 3.807M | 93.693M | 2,461.07% |
| Q3 2022 Q2Q % growth | 1.785M | -1.785M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | -16.39% |
| Revenue | 0% | 0% | 0% | 86.41% |